# OptimizeRx (OPRX) — Earnings

OPRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/oprx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.16 |
| EPS estimate | $0.11 |
| EPS surprise | +44.01% |
| Revenue surprise | +1.46% |
| Revenue | $20.5M |
| Revenue estimate | $20.2M |
| Reported | Aug 12, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1448431/000144843126000016/oprx-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/2d3e0e72-6312-dfbe-d769-ec06b756b741.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 12, 2026 | $0.11 | $0.16 | 44.01% | $20.2M | $20.5M |
| Q1 2026 | May 12, 2026 | $0.00 | $0.14 | 4142.42% | $18.4M | $19.8M |
| Q4 2025 | Mar 5, 2026 | $0.22 | $0.51 | 127.27% | $30.9M | $32.2M |
| Q3 2025 | Nov 6, 2025 | $0.04 | $0.20 | 442.01% | $23.5M | $26.1M |
| Q2 2025 | Aug 7, 2025 | $0.02 | $0.24 | 1337.13% | $22.3M | $29.2M |
| Q1 2025 | May 12, 2025 | −$0.12 | $0.08 | 166.67% | $18.7M | $21.9M |
| Q4 2024 | Mar 12, 2025 | $0.27 | $0.30 | 10.33% | $30.7M | $32.3M |
| Q3 2024 | Nov 13, 2024 | $0.06 | $0.12 | 103.39% | $25.0M | $21.3M |
| Q2 2024 | Aug 8, 2024 | −$0.06 | $0.02 | 131.06% | $20.2M | $18.8M |
| Q1 2024 | May 14, 2024 | −$0.13 | −$0.11 | 13.79% | $18.1M | $19.7M |
| Q4 2023 | Apr 2, 2024 | $0.38 | $0.26 | -32.22% | $27.9M | $28.4M |
| Q3 2023 | Nov 6, 2023 | $0.03 | $0.09 | 260.00% | $15.1M | $16.3M |
| Q2 2023 | Aug 14, 2023 | −$0.02 | −$0.01 | 53.27% | $14.8M | $13.8M |
| Q1 2023 | May 10, 2023 | −$0.08 | −$0.09 | -12.50% | $12.4M | $13.0M |
| Q4 2022 | Mar 8, 2023 | $0.24 | $0.25 | 3.56% | $21.8M | $19.7M |
| Q3 2022 | Nov 8, 2022 | $0.03 | $0.07 | 107.10% | $14.9M | $15.1M |
| Q2 2022 | Aug 9, 2022 | $0.09 | $0.04 | -55.56% | $17.1M | $14.0M |
| Q1 2022 | May 4, 2022 | −$0.01 | −$0.01 | 16.67% | $13.5M | $13.7M |
| Q4 2021 | Feb 24, 2022 | $0.21 | $0.22 | 6.80% | $20.2M | $20.3M |
| Q3 2021 | Nov 9, 2021 | $0.13 | $0.09 | -30.77% | $15.1M | $16.1M |

## Frequently Asked Questions

### When did OptimizeRx (OPRX) last report earnings?

OptimizeRx last reported on Aug 12, 2026, covering fiscal Q2 2026.

### Did OPRX beat earnings estimates?

Yes. OptimizeRx reported EPS of $0.16 for Q2 2026 against a $0.11 estimate — a 44.01% beat.

### How much revenue did OPRX report last quarter?

OptimizeRx reported $20.5M in revenue for Q2 2026, against a consensus estimate of $20.2M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).